Duobrii .1 mg/g (Halobetasol Propionate and Tazarotene LOTION) .1 mg/g

Duobrii .1 mg/g lotion combines halobetasol propionate and tazarotene for topical application. This medication is designed to address specific skin conditions, offering a dual-action approach for targeted relief. Ideal for those seeking effective topical treatment options.

Strength

.1 mg/g

Pack Size

6 TUBE in 1 CARTON (0187-0653-03) / 3 g in 1 TUBE

Manufacturer / TM Owner

Bausch Health US, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Duobrii .1 mg/g lotion is primarily used for the treatment of plaque psoriasis in adults. This topical medication works by reducing inflammation and promoting skin cell turnover. It is often recommended for individuals experiencing persistent or severe psoriasis symptoms. The combination of halobetasol propionate and tazarotene targets both the inflammation and the overproduction of skin cells associated with psoriasis.

Side Effects

When applied as directed, Duobrii .1 mg/g lotion may help reduce redness, scaling, and itching associated with plaque psoriasis. Users often notice improvements in skin texture and appearance over time. However, individual results can vary, and it is important to follow the prescribed application guidelines for optimal effects.

Precautions & Warnings

Duobrii .1 mg/g lotion should be used with caution, especially on sensitive skin areas. Avoid contact with eyes, mouth, and open wounds. It is advisable to perform a patch test before widespread use to check for any adverse reactions. Consult a healthcare provider before use if you have any pre-existing skin conditions or allergies.

Avoid Interactions

Duobrii .1 mg/g lotion may interact with other topical medications, so it is important to inform your healthcare provider about all products you are using. Avoid using other topical treatments on the same area without medical advice. Additionally, certain skin care products or cosmetics may affect the efficacy or safety of this medication.

Frequently Asked Questions

Duobrii .1 mg/g lotion is used for the treatment of plaque psoriasis in adults. It combines halobetasol propionate and tazarotene to address inflammation and skin cell overproduction.

Duobrii .1 mg/g lotion should be applied as directed by your healthcare provider. Typically, a thin layer is applied to the affected areas once daily.

Common side effects may include skin irritation, redness, and itching at the application site. Severe or persistent side effects should be reported to a healthcare provider.

It is important to consult a healthcare provider before using Duobrii .1 mg/g lotion with other medications, especially other topical treatments.

Duobrii .1 mg/g lotion should be used with caution on sensitive skin. A patch test is recommended to check for any adverse reactions before widespread use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.